About

Sheila Trgovac, Vice-President, Strategic Development, Ximedica, partners with clients to translate their strategic objectives into meaningful development of innovative and impactful healthcare products. She draws on her extensive experience in product development and marketing to help clients bring new products to market faster, more efficiently and with greater market potential and impact at every stage of the development process.

Ms Trgovac has 12 years’ experience in medical device, pharmaceutical, business management, account management, marketing and, most recently, drug delivery device development. She has a BSc in Bioengineering from Penn State University (PA, US) and a Masters in Management from Harvard University (MA, US).

Contributions

CONNECTIVITY

HOW DIGITAL TECHNOLOGY CAN TRANSFORM CLINICAL TRIALS

Sheila Trgovac and Rebecca Ford suggest that now is the time for innovation in clinical trials – using a patient-centric approach whilst leveraging digital solutions to create a digital clinical trial ecosystem.

More contributions

INJECTION

THE CHALLENGES OF A CHANGING MARKET & THE BENEFITS OF DEVELOPMENT FLEXIBILITY

David Fink and Sheila Trgovac describe how adopting a flexible development model in mid-to-late development brings benefits through to commercialisation, especially in the context of a changing market.